Acceptability of and treatment preferences for recurrent bacterial vaginosis—Topical lactic acid gel or oral metronidazole antibiotic: Qualitative findings from the VITA trial

Jocelyn Anstey Watkins; Jonathan D.C. Ross; Sukhwinder Thandi; Clare Brittain; Joe Kai; Frances Griffiths

doi:10.1371/journal.pone.0224964

Acceptability of and treatment preferences for recurrent bacterial vaginosis—Topical lactic acid gel or oral metronidazole antibiotic: Qualitative findings from the VITA trial

Jocelyn Anstey Watkins^*, Jonathan D.C. Ross, Sukhwinder Thandi, Clare Brittain, Joe Kai, Frances Griffiths

^*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

24 Citations (SciVal)

Original language	English
Article number	e0224964
Journal	PLoS ONE
Volume	14
Issue number	11
DOIs	https://doi.org/10.1371/journal.pone.0224964
Publication status	Published (VoR) - 1 Nov 2019

Access to Document

10.1371/journal.pone.0224964

Cite this

@article{83fa30fdb2034993b014c0080b4f39b7,

title = "Acceptability of and treatment preferences for recurrent bacterial vaginosis—Topical lactic acid gel or oral metronidazole antibiotic: Qualitative findings from the VITA trial",

author = "Watkins, \{Jocelyn Anstey\} and Ross, \{Jonathan D.C.\} and Sukhwinder Thandi and Clare Brittain and Joe Kai and Frances Griffiths",

note = "Publisher Copyright: {\textcopyright} 2019 Anstey Watkins et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.",

year = "2019",

month = nov,

day = "1",

doi = "10.1371/journal.pone.0224964",

language = "English",

volume = "14",

journal = "PLoS ONE",

issn = "1932-6203",

publisher = "Public Library of Science",

number = "11",

}

Acceptability of and treatment preferences for recurrent bacterial vaginosis—Topical lactic acid gel or oral metronidazole antibiotic: Qualitative findings from the VITA trial. / Watkins, Jocelyn Anstey; Ross, Jonathan D.C.; Thandi, Sukhwinder et al.
In: PLoS ONE, Vol. 14, No. 11, e0224964, 01.11.2019.

Research output: Contribution to journal › Article › peer-review

TY - JOUR

T1 - Acceptability of and treatment preferences for recurrent bacterial vaginosis—Topical lactic acid gel or oral metronidazole antibiotic

T2 - Qualitative findings from the VITA trial

AU - Watkins, Jocelyn Anstey

AU - Ross, Jonathan D.C.

AU - Thandi, Sukhwinder

AU - Brittain, Clare

AU - Kai, Joe

AU - Griffiths, Frances

N1 - Publisher Copyright: © 2019 Anstey Watkins et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

PY - 2019/11/1

Y1 - 2019/11/1

UR - https://www.scopus.com/pages/publications/85075174930

UR - https://www.scopus.com/inward/citedby.url?scp=85075174930&partnerID=8YFLogxK

U2 - 10.1371/journal.pone.0224964

DO - 10.1371/journal.pone.0224964

M3 - Article

C2 - 31730666

AN - SCOPUS:85075174930

SN - 1932-6203

VL - 14

JO - PLoS ONE

JF - PLoS ONE

IS - 11

M1 - e0224964

ER -

Acceptability of and treatment preferences for recurrent bacterial vaginosis—Topical lactic acid gel or oral metronidazole antibiotic: Qualitative findings from the VITA trial

Access to Document

Other files and links

Fingerprint

Cite this